Indraprastha Medical Corporation Limited (IN:INDRAMEDCO)

:INDRAMEDCO

INDRAMEDCO

Indraprastha Medical Corporation Limited

RESEARCH TOOLSreports

Want to see IN:INDRAMEDCO full AI Analyst Report?

Indraprastha Medical Corporation Limited (INDRAMEDCO) Price & Analysis

3 Followers

INDRAMEDCO Stock Chart & Stats

₹456.05

-₹15.75(-2.78%)

At close: Jan 08 4:00 PM EST

₹456.05

-₹15.75(-2.78%)

Day’s Range― - ―

52-Week Range₹342.35 - ₹640.05

Previous CloseN/A

Volume350.29K

Average Volume (3M)33.92K

Market Cap

₹37.99B

Enterprise Value₹32.87B

Total Cash (Recent Filing)₹4.61B

Total Debt (Recent Filing)₹313.40M

Price to Earnings (P/E)25.1

Beta1.43

Next Earnings

May 15, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.96%

Share Statistics

EPS (TTM)4.80

Shares Outstanding91,673,000

10 Day Avg. Volume18,340

30 Day Avg. Volume33,918

Financial Highlights & Ratios

PEG Ratio0.75

Price to Book (P/B)6.04

Price to Sales (P/S)2.66

P/FCF Ratio29.92

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)21.5

Revenue Forecast (FY)₹15.98B

Bulls Say, Bears Say

Bulls Say

Multi-year Revenue GrowthSustained revenue growth over multiple years reflects expanding patient volumes and service mix at the hospital. That scale supports fixed-cost absorption and long-term revenue resilience, providing a durable foundation for earnings stability and reinvestment over the next 2–6 months.

Improving Margins And EfficiencyRising gross and net margins indicate stronger pricing, better cost controls and improved clinical operating efficiency. Margin expansion enhances cash generation and operational resilience, making profitability more sustainable across medium-term cycles and supporting future investments.

Low Leverage, Strong Equity PositionA low-debt capital structure and improved ROE provide financial flexibility for capex, working capital and buffer in downturns. Strong equity and limited leverage reduce refinancing risk and preserve capacity to fund strategic initiatives without compromising solvency.

Bears Say

Declining Cash BalancesA year-over-year drop in cash reserves signals tighter liquidity, which can constrain short-term operational flexibility and payment cycles. If sustained, lower cash balances raise the importance of careful working-capital management and may limit rapid response to demand or investment opportunities.

Weaker Operating/free Cash Flow In 2025Reduced operating and free cash flow undermines the company's ability to self-fund capex, service working capital and maintain discretionary spending. Over the medium term this can pressure liquidity buffers and elevate reliance on external financing if cash trends do not reverse.

Exposure To Payor/reimbursement DynamicsSignificant reliance on insurers, TPAs and negotiated tariffs creates structural revenue and margin exposure to payor negotiations and regulatory tariff changes. Such dynamics can compress pricing power and margins over time unless offset by volume growth or cost efficiencies.

INDRAMEDCO FAQ

What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?

Indraprastha Medical Corporation Limited lowest stock price was ₹342.35 and its highest was ₹640.05 in the past 12 months.

What is Indraprastha Medical Corporation Limited’s market cap?

Indraprastha Medical Corporation Limited’s market cap is ₹37.99B.

When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?

Indraprastha Medical Corporation Limited’s upcoming earnings report date is May 15, 2026 which is in 16 days.

How were Indraprastha Medical Corporation Limited’s earnings last quarter?

Indraprastha Medical Corporation Limited released its earnings results on Feb 03, 2026. The company reported ₹4.8 earnings per share for the quarter, beating the consensus estimate of N/A by ₹4.8.

Is Indraprastha Medical Corporation Limited overvalued?

According to Wall Street analysts Indraprastha Medical Corporation Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Indraprastha Medical Corporation Limited pay dividends?

Indraprastha Medical Corporation Limited pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.96%. See more information on Indraprastha Medical Corporation Limited dividends here

What is Indraprastha Medical Corporation Limited’s EPS estimate?

Indraprastha Medical Corporation Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Indraprastha Medical Corporation Limited have?

Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding.

What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?

Indraprastha Medical Corporation Limited reported an EPS of ₹4.8 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 5.119%.

Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?

Currently, no hedge funds are holding shares in IN:INDRAMEDCO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Indraprastha Medical Corporation Limited

Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, pediatric, elder care, genomic medicine, health check, sugar, bariatric and metabolic surgery, bone marrow transplant, cancer, cardiac and cardiology, dermatology, dietetics and clinical nutrition, emergency care, endovascular surgery, endocrinology/diabetes care, ENT, fetal medicine, gastroenterology and hepatology, laparoscopic surgery, gynecology and obstetrics, hyperbaric oxygen therapy, IVF, internal medicine, laboratory services, neonatology, nephrology, neurosciences, nuclear medicine, ophthalmology, orthopedic, pediatric urology and pediatric surgery, physiotherapy and rehabilitation, psychiatry and clinical psychology, radiology/radio diagnosis, respiratory sleep medicine and critical care, rheumatology, robotic surgery, spine surgery, transfusion medicine, transplant, and urology and andrology. The company operates cosmetic and dental clinics. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India.